Header cover image

Australian (ASX) Healthcare Sector Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
Companies174
  • 7D-2.2%
  • 3M-1.7%
  • 1Y5.1%
  • YTD9.4%

Over the last 7 days, the Healthcare industry has dropped 2.2%, driven by a pullback from CSL of 3.2%. This takes the industry's 12 month performance to a gain of 5.1%.

Sector Valuation and Performance

Has the Australian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Tue, 30 Nov 2021AU$239.5bAU$56.1bAU$4.7b30.4x
Thu, 28 Oct 2021AU$234.5bAU$55.2bAU$4.5b30.2x
Sat, 25 Sep 2021AU$241.4bAU$55.6bAU$4.6b30.8x
Mon, 23 Aug 2021AU$238.6bAU$55.1bAU$4.5b29.6x
Sat, 10 Jul 2021AU$226.8bAU$55.1bAU$4.5b30.7x
Fri, 02 Apr 2021AU$208.7bAU$52.5bAU$3.8b23.1x
Mon, 04 Jan 2021AU$211.4bAU$50.7bAU$3.1b31.9x
Thu, 08 Oct 2020AU$210.2bAU$50.3bAU$2.8b30.5x
Wed, 01 Jul 2020AU$204.0bAU$49.6bAU$2.5b27.4x
Sat, 04 Apr 2020AU$192.9bAU$51.5bAU$3.5b20.6x
Tue, 07 Jan 2020AU$197.2bAU$49.6bAU$3.7b21.4x
Mon, 30 Sep 2019AU$175.7bAU$49.4bAU$3.8b20.6x
Thu, 04 Jul 2019AU$164.3bAU$47.7bAU$3.6b22.3x
Sun, 07 Apr 2019AU$146.2bAU$46.5bAU$3.5b21.4x
Wed, 09 Jan 2019AU$136.4bAU$45.3bAU$3.4b22.9x
PE Ratio

20.4x

Total Market Cap: AU$131.9bTotal Earnings: AU$3.3bTotal Revenue: AU$44.0b0%0%0%3 Year10 Year
201920202021

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 25.7x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 12% per year over the last three years, and revenues for these companies have grown 8.4% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Australian Healthcare sector?

Healthtech1.54%
Healthcare Services0.14%
Medical Equipment-0.66%
Life Sciences-1.93%
Biotech-3.36%
Pharma-3.78%

Industry PE: Investors are most optimistic about the Healthtech industry, which is trading close to its 3-year average PE ratio of 123x. However analysts expect its future annual earnings growth (36%) to be largely in line with prior year's earnings growth, so the market might believe analysts are underestimating its future growth since investors are willing to pay a bigger premium today. Meanwhile, investors are most pessimistic about the Medical Equipment industry, which is trading below its 3-year average of 32.2x.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 67% over the next 5 years. This is better than it's past earnings growth rate of 5.6% per year. Meanwhile, the Healthcare Services industry is expected to see its earnings growth to stay flat over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company7D1YValuation
SHL Sonic Healthcare3.3%+AU$647.5m28.5%n/a
PME Pro Medicus4.1%+AU$255.7m108.6%n/a
IDT IDT Australia48.8%+AU$48.0m229.7%n/a
ANN Ansell1.0%+AU$39.5m-15.8%n/a
BIT Biotron84.0%+AU$29.5m10.8%n/a
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CSL

AU$306.79

CSL

7D

-3.2%

1Y

2.3%

COH

AU$217.80

Cochlear

7D

-5.2%

1Y

-3.1%